# JALYN
> **NDA022460** · New Drug Application · Sponsor: WAYLIS THERAP · Approved 2010-06-14
## Drug
- **FDA Application Number:** NDA022460
- **Application type:** New Drug Application
- **Brand name:** JALYN
- **Generic name:** DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE
- **Active ingredients:** DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** WAYLIS THERAP
- **Manufacturer:** Waylis Therapeutics
- **First approval:** 2010-06-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022460)
---
*AI Analytics · CC0 1.0*